Imio raises $12M seed for freeze-dried crop microbes, a Belgian food first
What's the deal? ImioDealroom has a profile for this one. Try Dealroom →, a Belgian startup developing freeze-dried biologicals to boost soil health and crop yields, has raised $12 million in seed funding. Sofinnova Partners led the round, which was announced in October 2026.
By the numbers: The raise ranks in the top 1% of all seed rounds for food startups in Belgium, based on a sample of 76 deals. Imio's flagship Re-Gen line uses microbial technology to break down crop residue and unlock fertilizer value.
Why now? Farmers are seeking reliable alternatives to nitrogen fertilizers, which have soared in price. Imio pitches its biologicals as a way to improve yields and soil health while managing those costs.
What's the endgame? Imio builds biological inputs designed to work across the crop nutrient cycle. Re-Gen targets commercial row-crop and produce growers, using microbes to rapidly break down residue and cut unnecessary tillage passes.
What could go wrong? The open question is whether Imio's freeze-dried microbes can deliver reliable, field-proven results at a price and scale that farmers will adopt.
The signal: The round lands amid steady investor and strategic interest in crop biologicals. Robigo Bio raised a Series A in September led by BayerDealroom has a profile for this one. Try Dealroom →'s venture arm, BASF acquired AgBiTechDealroom has a profile for this one. Try Dealroom → to expand its biological portfolio, and BioConsortia secured $15 million to scale microbial seed treatments — a sign that both startups and incumbents are betting on microbes as fertilizer prices push growers toward alternatives.
Read more: Axios
Image credit: Imio
